Clinical Trial

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025

Study acronym: EPOOzo
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 2, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main objective of this study is to analyze the impact on the health-related quality of life of patients with refractory symptoms, who have been referred to the HUGCDN Chronic Pain Unit for adjuvant palliative treatment with ozone therapy between June-2022 and December-2025
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-06-09; most recent amendment 2025-08-25.
Status change: Not Yet Recruiting → Recruiting 2022-06-15
Trial Details
NCT Number NCT05417737
Lead Sponsor Bernardino Clavo, MD, PhD
Collaborators: Fundación Canaria Instituto de Investigación Sanitaria de Canarias, Servicio Canario de Salud, Council of Gran Canaria, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna
Conditions Radiation Toxicity, Chemotherapeutic Toxicity, Chemotherapy-induced Peripheral Neuropathy, Delayed Wound Healing, Chronic Pain, Refractory Pain
Enrollment 105 participants
Start Date 2022-06-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-02